ReleaseWire

Global governments see a range of opportunities in terms of defense, security, and public safety related improvements possible by leveraging massive amounts of data available in modern society. The US Government in particular sees data of various types (structured and unstructured) and from various sources as an opportunity to continuously improve predictive capabilities regarding its defense and homeland security programs.

Bring your own device (BYOD) has become one of the most popular topics in information technology resulting from employees bringing their personal devices into the enterprise and then wanting to use them to access company information such as email and various enterprise files. As the trend continues, bring your own technology will eventually facilitate user's integrating many device types (smartphones, tablets, wearable technology), software, and services with those from the enterprise. Mind Commerce estimates that there will be 2 billion BYOD devices in workplace by 2020.

Global Wallpaper Industry Report 2015 is a professional and in-depth study on the current state of the Wallpaper industry.

This report is the result of WealthInsight's extensive research covering the high net worth individual (HNWI) population and wealth management market in the UK.

This report shows the leading Government Biometric Systems market segments in various regions across the world. Details of top companies active across the global Government Biometric Systems market are provided, together with market size and forecast 2013-2023 for the main players across those areas.

The Future of the Portuguese Defense Industry – Market Attractiveness, Competitive Landscape and Forecasts to 2020, published by Strategic Defence Intelligence, provides readers with detailed analysis of both historic and forecast defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news.

This report offers detailed analysis of the global Government Biometric Systems market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Government Biometric Systems market.

This report provides information on major programs planned in the global Government Biometric Systems market. It provides details on top programs in each segment expected to be executed during the forecast period.

This report provides readers with a comprehensive analysis of the Government Biometric Systems market through 2013-2023, including highlights of the demand drivers and growth stimulators for Government Biometric Systems. It also provides an insight on the spending pattern and modernization pattern in different regions around the world.

Do you ever feel like you are continually experiencing crisis or challenges day in and day out? Would you like to learn how to cope with these challenges with Grace and tap into Courage? Join me and my guest, best-selling author of "Simple Steps Real Change" Cheryl Maloney, as we discuss Cheryl's simple steps that lead to real change. There will be a Q&A portion where we will open the phone lines to your questions by calling, 888-346-9141.

Masimo Corporation (Masimo) is a global medical technology company. It manufactures and distributes non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. Signal Extraction Technology (SET) is the company's lead technology that helps detect life threatening events. Other technologies of Masimo include Pulse CO-Oximetry which allows noninvasive and continuous monitoring of blood constituents, brain and breathand Patient SafetyNet, a remote monitoring and wireless clinician notification system. The company's key products include pulse oximeters, patient monitors, patient cables, central monitoring systems, specialty sensors, circuit boards, remote-alarm, and monitoring solutions. It markets these products directly and through distributors and original equipment manufacturers (OEMs) to hospitals, emergency medical services (EMS), physician offices, veterinarians, long term care facilities, and consumers market. The company operates in various markets across North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.

Varian Medical Systems, Inc. (Varian) is a provider of medical devices and software for the treatment of cancer. It designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. The company offers X-ray tubes and digital image detectors that are used in medical, dental, veterinary, scientific and industrial sectors. It designs, manufactures, sells and services linear accelerators, image processing software and image detection products for security and inspection purposes and proton therapy products and systems for cancer treatment. The company, together with its subsidiaries and manufacturing facilities, operates in North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US.Varian secured the US FDA approval for several products including Truebeam Stx-Edge radiotherapy delivery system Varian Head Frame Varian Verification system Universal Segmented Cylinder Applicator and Smart Segmentation Knowledge Based Contouring system, among others. These approvals enable the company to expand its operations in the US.

Merit Medical Systems, Inc. (Merit) offers a wide variety of single-use medical devices for use in interventional and diagnostic procedures. The company's products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic catheters and fluid dispensing systems, and embolotherapeutic products. These products find applications in various diagnostic and interventional cardiology fields such as radiology, cardiology, and endoscopy. Merits products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, oncology, and pain management. The company markets its products through direct sales force in the US and Europe, and China and through independent dealer organizations and network of OEM partners in the Europe, Africa, the Middle East, Asia, South and Central America, Oceania, and Canada. Merit is headquartered in South Jordan, Utah, the US.The company focuses on expanding its product portfolio through constant innovations. To this end, Merit obtained regulatory approvals for its ReSolve biliary locking drainage catheter, ONE Snare endovascular microsnare system, and AEROmini tracheobronchial stent system.

BioMark Technologies Inc. (BioMark Technologies) is a biotechnology service providing company which develops and provides a range of portable screening tools for the treatment of cancers. The company manufactures and distributes diagnostic systems for the detection and diagnosis of cancer. It offers its technology for diagnosis, response to treatment, prognosis and drug therapy. BioMark Technologies partners with various other healthcare providers, universities and research and development organizations. The company has its presence in China and Canada. BioMark Technologies is headquartered in Richmond, British Columbia, Canada.

Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that manufactures diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It has over 140 diagnostic tests and transport media, spanning from prenatal care, respiratory infections, and organ transplant infections among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices, and diagnostics manufacturers in over 60 countries the world over. Meridian is headquartered in Ohio, the US.Meridian seeks to establish development and marketing partnerships, research collaborations, technology in-licensing with other companies which would enhance the company's capabilities, clinical program and product pipeline. The company focuses on its product portfolio expansion by building strong operating base besides gaining expertise through strategic agreements and collaborations.

Listeners can get their questions about effective leadership in business and at home answered Tuesday, May 5, 2015, on voiceamerica.com/show/2397/family-matters. Entrepreneur, marketing strategist, negotiations architect, speaker, and author of CDO Chief Daddy Officer®-The Business of Fatherhood, Chris Efessiou understands first hand that the dynamics of success are the same whether you are addressing a group at work or tucking your child into bed at night. As the number of children living in single-parent households has exponentially increased, a new generation of working parents has evolved.

Human augmentation, also known as Human 2.0, refers to technologies that are used for bringing physical improvement in the integral parts of the human body. Technological advancements in IT have led to the introduction of a greater variety of implants and other technologies, which are used for human augmentation. In addition, genetic engineered human technologies also play an important role in the treatment of various diseases and disabilities.

Blood disorders are caused due to lack of blood components. These components include red blood cells, white blood cells, and platelets. Anemia, leucopenia, and thrombocytopenia are some of the common blood disorders. Some of the common symptoms of blood diseases include fatigue, headache, weakness, fever, infections, and bleeding. Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body's inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack of red blood cells in blood, which in turn results in a decrease in platelet numbers. This decrease in platelet number causes anemia and thrombosis. Anemia is a blood condition characterized by less number of red blood cells. Loss of blood is the commonest cause of anemia and it further results in chronic outcomes. Thrombosis refers to the formation of blood clot in blood vessels. Some of the common types of orphan blood disease, which lead to acquired orphan blood diseases, include Paroxysmal Nocturnal Hemoglobinuria (PNH), Idiopathic Thrombocytopenic Purpura (ITP), Myelodysplastic Syndrome (MDS), Myelofibrosis (MF), and Polycythemia Vera (PV). PNH is a common blood disease characterized by severe anemia. Some of the available treatment options for acquired orphan blood disease include medication, bone marrow transplant, blood transfusion, and iron therapy.

Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles. Bladder cancers are basically of two types: muscle-invasive and non-muscle invasive. When the tumor is inside the lining of bladder, it is termed as superficial or non-muscle-invasive bladder cancer. It is the most common type of bladder cancer, and is less fatal. When the tumor spreads beyond the lining of the bladder, it is termed as muscle-invasive bladder cancer; it is very rare and fatal. These bladder cancers can be further segmented into low-grade and high-grade tumors, on the basis of their malignant potential. The standard treatment for non-muscle-invasive bladder cancer is transurethral resection of the bladder tumor. It is further followed by perioperative chemotherapy. Since bladder cancer is frequently recurrent, patients need to undergo diagnosis after every one year. The bladder cancer treatment drugs market is growing at a significant rate due to the increasing prevalence of bladder cancer and growing awareness about the types of bladder cancers and their treatment.

Silent cancer refers to those types of cancer which are undiagnosed in early stages. This is due to asymptomatic nature of the disease which makes it difficult to identify the disease till it progresses to advanced stages. Major silent types of cancer include brain, cervix, esophagus, mouth and larynx, ovarian, pancreatic, kidney, and liver cancer. Some silent types of cancer such as ovarian cancer, esophageal cancer, and pancreatic cancer show symptoms in their early stages. Ovarian cancer occurs in epithelium or lining cells of the ovary. Major signs and symptoms of ovarian cancer include pain or cramps in the belly, nausea, abnormal vaginal bleeding, and bloating. Pancreatic cancer is one of the fastest growing types of cancer worldwide. Esophagus cancer is more common among the older population, compared to adults. This cancer is mainly treated by chemotherapy, surgery, and radiosurgery. Moreover, physicians also use combination therapy for the treatment of silent cancer. For instance, the combination of radiation therapy and chemotherapy is very effective in the treatment of silent cancer.

Single-use, also known as disposable, refers to products that are intended for one-time use. These products are made from a plastic (polyamide {PA}, polyethylene {PE}, polycarbonate {PC}, polyethersulfone {PESU}, polypropylene {PP}, polyvinyl chloride {PVC}, polytetrafluorethylene {PTFE}, cellulose acetate {CA}, and ethylene vinyl acetate {EVA}) and are disposed after use. Single-use products have revolutionized the field of bioproduction. These products are becoming popular in the biopharmaceutical arena as they reduce the risk of contamination during development and production. Various disposable products such as laboratory instruments, including petri plates, flasks, filling and tubing systems, cell culture apparatus, filters, pumps, bioreactors, are used in bioproduction.

Attention-deficit hyperactivity disorder (ADHD) refers to a developmental neuropsychiatric disorder owing to which a person loses control over her/his executive functions, including attentional and inhibitory control. As a result, it may lead to attention deficit, hyperactivity, or impulsiveness. Treatment for attention-deficit hyperactivity disorder includes medications, lifestyle changes, and counseling. This disorder is more common in children below 12 years of age and the cause behind this disorder is still unknown. Common symptoms for attention attention-deficit hyperactivity disorder are difficulty in maintaining focus on one task, being easily distracted, missing details, forgetting things, frequent tendencies to switch from one activity to another, impatience, being constantly in motion, and having difficulty in doing quiet tasks or activities. Medications for attention-deficit hyperactivity disorder may be classified into stimulants, nonstimulants, and others. The market for attention-deficit hyperactivity disorder therapeutics is increasing at a significant rate due to increasing number of attention-deficit hyperactivity disorder cases worldwide.

The much awaited biosimilars have finally entered the US pharmaceutical market with the FDA approval of Sandoz's Zarxio, a G-CSF. The move is expected to make US a significant region for biosimilar activity.

According to a new research report by RNCOS entitled, "Global Influenza Vaccine Market Outlook 2020", US dominates the influenza vaccine market in the world and the emerging countries of Asia Pacific region is expected to capture a significant share in the Global Influenza Vaccine Market.

While most authors use their debut novel to do nothing but test the literary waters, James K. West is quickly proving that a first release is also an opportunity to rival a genre's bestsellers.